Long-term Use of Proton Pump Inhibitors Is Associated With Increased Microbial Product Translocation, Innate Immune Activation, and Reduced Immunologic Recovery in Patients With Chronic Human Immunodeficiency Virus-1 Infection
2017 ◽
Vol 65
(10)
◽
pp. 1638-1643
◽
2011 ◽
Vol 204
(5)
◽
pp. 753-760
◽
2003 ◽
Vol 71
(4)
◽
pp. 600-607
◽
2004 ◽
Vol 23
(8)
◽
pp. 713-718
◽